{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-cough/management/symptomatic-treatment/","result":{"pageContext":{"chapter":{"id":"7cb56d6a-7186-5fc1-9c6b-0f3af49e4b20","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment","depth":2,"htmlHeader":"<!-- begin field 359ee0f0-4e17-4681-99ce-c865dd253ba7 --><h2>Scenario: Symptomatic treatment</h2><!-- end field 359ee0f0-4e17-4681-99ce-c865dd253ba7 -->","summary":"Covers the palliative cancer care management of a person with cough of unknown cause, including symptomatic management of dry and moist cough.","htmlStringContent":"<!-- begin item 0a86cd56-2c80-46be-84e8-e68fe47d92d1 --><!-- begin field b4a7e7ef-211e-4bb3-9203-acbd008698c0 --><p>From age 16 years onwards.</p><!-- end field b4a7e7ef-211e-4bb3-9203-acbd008698c0 --><!-- end item 0a86cd56-2c80-46be-84e8-e68fe47d92d1 -->","topic":{"id":"d321ef5c-4612-5a6b-aafc-a656ec8fb1e6","topicId":"561865b5-2a09-480f-ae63-783b229b69bf","topicName":"Palliative care - cough","slug":"palliative-care-cough","lastRevised":"Last revised in April 2020","chapters":[{"id":"bce97da8-92b8-599d-88a3-f95ee1c136d2","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ff610ad5-9e7b-56ea-8eac-bfd602137594","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8409825-4431-5ee0-9294-3c43a9596f99","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e1226b71-f64b-5a62-81df-0219b18ce529","slug":"changes","fullItemName":"Changes"},{"id":"3ad0995f-5610-51ce-bb35-457850cd484e","slug":"update","fullItemName":"Update"}]},{"id":"d7bb7e5e-514b-547f-9b69-4fb3327ec125","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"74afa2f6-d51b-5cbd-b460-b6e4d03732af","slug":"goals","fullItemName":"Goals"},{"id":"34cc375e-0ca3-5323-a1cd-021d11c018db","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a037a0d5-cb13-59dc-94c7-55040a012faf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9342453d-dbf4-55fb-b5dc-50216b89f42b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bd5feaf8-f260-59ed-9474-23ad808b0e62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00a6af51-79f3-5510-a3e6-1f4f8c942f40","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5811a833-882d-55ab-a3f5-09d1feff4254","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2bfea1d4-d4ce-5066-af76-c1bc08c5c287","slug":"purpose-mechanism-of-cough","fullItemName":"Purpose and mechanism of cough"},{"id":"e6e866d7-040b-5653-a045-a47d96b61bda","slug":"prevalence-of-cough-in-palliative-care","fullItemName":"Prevalence of cough in palliative care"},{"id":"848fec2b-a258-59bb-99e5-11ab01a40295","slug":"causes-of-cough-in-palliative-care","fullItemName":"Causes of cough in palliative care"},{"id":"b7268bf0-d5b4-5fde-9016-68778770d8ad","slug":"complications-of-cough","fullItemName":"Complications of cough"}]},{"id":"82094bd0-c604-5bbf-acb9-8de75cf96107","fullItemName":"Management","slug":"management","subChapters":[{"id":"b6ff7bf7-561f-55f0-ad57-2373c98c25a4","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"59d61f62-958b-56b8-8aa4-2cfb39def0c1","slug":"known-cause-of-cough","fullItemName":"Scenario: Known cause of cough"},{"id":"7cb56d6a-7186-5fc1-9c6b-0f3af49e4b20","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment"},{"id":"36252764-f5e9-5b31-ad0b-ba291aef89e7","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"},{"id":"350b3d29-e254-59ab-a297-4fad68eecad4","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"644dd5b8-ece9-502a-be3e-f0527653ac64","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bdaa86d3-a323-594c-b17f-71e8f0252c4c","slug":"nebulized-sodium-chloride","fullItemName":"Nebulized sodium chloride"},{"id":"b13d017f-af1d-5851-8c0e-967352e91bde","slug":"pholcodine-linctus-bp","fullItemName":"Pholcodine linctus BP"},{"id":"03f99c3c-08ce-5899-9fbe-4f57a0f2904f","slug":"codeine","fullItemName":"Codeine"},{"id":"60a78c3d-94b2-5e08-9e65-8bafd18725ba","slug":"morphine","fullItemName":"Morphine"},{"id":"45d8e905-93b4-585b-b370-12c26491e7e4","slug":"mucolytics","fullItemName":"Mucolytics"}]},{"id":"6c7c1d77-3b02-5361-979b-ceb31387e824","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"dd028d8e-6a48-5f6d-924a-d3970c3b0df9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"26cda216-c628-5c3c-9604-cff1e8a0a730","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f586cb3d-0420-52a2-ac78-fd155050abc9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9c55540f-e0ca-5527-8e1b-676719b74676","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"38ff8a0d-a949-566e-b696-ee543d5b835e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3f4f13e9-8e87-5cc5-b27e-0ef15bf0ac38","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b3492817-f33c-53f6-8da4-2144cd1afa9f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"82094bd0-c604-5bbf-acb9-8de75cf96107","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"e08ee618-79a4-5c92-a7c7-fea0c558ca87","slug":"when-to-consider-symptomatic-treatment","fullItemName":"When to consider symptomatic treatment","depth":3,"htmlHeader":"<!-- begin field 1dc0e606-cb84-425a-a94d-c3a075deb436 --><h3>When should I consider symptomatic treatment for cough?</h3><!-- end field 1dc0e606-cb84-425a-a94d-c3a075deb436 -->","summary":null,"htmlStringContent":"<!-- begin item 70fcc4b9-7c07-4c28-b33e-1c3029065916 --><!-- begin field aa9b46b7-5704-4384-8476-80eb76b30f11 --><ul><li>Consider symptomatic treatment if one or more of the following applies:<ul><li>The option of treating the underlying cause is not possible or is inappropriate.</li><li>The person remains distressed by symptoms despite treatment of the underlying cause.</li><li>The person is in the terminal phase of life. For information on recognizing the terminal phase, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative cancer care - general issues</a>.</li></ul></li></ul><!-- end field aa9b46b7-5704-4384-8476-80eb76b30f11 --><!-- end item 70fcc4b9-7c07-4c28-b33e-1c3029065916 -->","subChapters":[{"id":"57b4f171-6231-54ee-be79-5038bbf16924","slug":"basis-for-recommendation-c36","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 243705a2-452e-45a5-9acc-5ff68be7182a --><h4>Basis for recommendation</h4><!-- end field 243705a2-452e-45a5-9acc-5ff68be7182a -->","summary":null,"htmlStringContent":"<!-- begin item c36f99ee-f403-4188-be19-b90e0664083a --><!-- begin field b2b516ef-bdc8-4c94-9f8f-73d7c30d5e87 --><p>These recommendations are based on pragmatic advice and expert opinion from the palliative care literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Ahmedzai, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Estfan and LeGrand, 2004</a>].</p><ul><li>Cough may be very distressing in the terminal phase of cancer. The act of coughing may cause or aggravate pain, it may disturb sleep, and it can impede communication between people with cancer and their carers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Ahmedzai, 2004</a>].</li></ul><!-- end field b2b516ef-bdc8-4c94-9f8f-73d7c30d5e87 --><!-- end item c36f99ee-f403-4188-be19-b90e0664083a -->","subChapters":[]}]},{"id":"6493ce05-4fe1-5010-a60d-98ea313fd484","slug":"dry-cough","fullItemName":"Dry cough","depth":3,"htmlHeader":"<!-- begin field 9f5be5e4-5a54-4c71-b4ea-adbca9f2bb6d --><h3>How should I manage a dry cough symptomatically in palliative care?</h3><!-- end field 9f5be5e4-5a54-4c71-b4ea-adbca9f2bb6d -->","summary":null,"htmlStringContent":"<!-- begin item cfb03127-b1b2-49db-92d0-a1776321a11a --><!-- begin field 563ab8b4-353e-4365-91a1-ae90769c988b --><ul><li>With symptomatic management, adopt a stepwise approach.</li><li>Use simple measures first — humidify room air, try Simple Linctus BP.</li><li>If symptom relief is not adequate, use a weak opioid cough suppressant (unless the person is already on a strong opioid for pain) — Pholcodine Linctus BP 10 mL (5 to 10 mg) three to four times a day, or Codeine Linctus BP 5 mL to 10 mL (15 mg to 30 mg) three to four times a day, or codeine phosphate tablets 15 mg to 30 mg every 4 hours.</li><li>If the cough is still persistent despite using a weak opioid cough suppressant, switch to morphine 5 to 10 mg every 4 hours and 'as required'. For people who are opioid naive, start with a dose of 2.5 to 5 mg every 4 hours.<ul><li>When using an opioid cough suppressant:<ul><li>Advise the person of the risks of constipation and prescribe a regular stimulant laxative. For further information on preventing constipation when prescribing opioids see the section <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-constipation/management/management/#preventing-constipation\">preventing constipation</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-constipation/\">Palliative care - constipation</a>.</li><li>Prescribe an anti-emetic (for example haloperidol or metoclopramide) regularly for the first week to prevent opioid-induced nausea and vomiting if the person has experienced nausea with a weak opioid, or on standby, for use on an 'as required' basis for a week, in case the person experiences nausea with morphine but has <em>not </em>previously had nausea with a weak opioid.</li></ul></li></ul></li><li>If all these measures fail, seek specialist advice, to discuss:<ul><li>Treatment of the underlying cause (such as with radiotherapy).</li><li>Use of sodium cromoglicate 10 mg inhaled 4 times a day (can improve cough in people with lung cancer within 36-48 hours).</li><li>Use of oral corticosteroids.</li><li>Use of a drug with nonspecific cough suppressant activity such as a (nebulized) local anaesthetic.<ul><li>Nebulized local anaesthetic options include, 2% lidocaine 5 mL or 0.25% bupivacaine 5 mL every 6–8 hours.</li><li>However, the use of nebulized local anaesthetics is limited by unpleasant taste, oropharyngeal numbness, risk of bronchoconstriction, and short duration of action (10–30 minutes).</li></ul></li></ul></li><li>If dyspnoea is a feature, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-dyspnoea/\">Palliative cancer care - dyspnoea</a>.</li></ul><!-- end field 563ab8b4-353e-4365-91a1-ae90769c988b --><!-- end item cfb03127-b1b2-49db-92d0-a1776321a11a -->","subChapters":[{"id":"a90a481a-7fa3-50ff-bf76-bcb06651a854","slug":"basis-for-recommendation-136","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f6393386-af3e-42c9-b0b8-e01c241788cf --><h4>Basis for recommendation</h4><!-- end field f6393386-af3e-42c9-b0b8-e01c241788cf -->","summary":null,"htmlStringContent":"<!-- begin item 1360b660-d094-4ac0-88ca-19eecc687914 --><!-- begin field 0b1c0b30-52f5-4c93-8ee2-3845d9ec34cf --><p>These recommendations are based on palliative care guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Kvale, 2006</a>] and expert opinion from the palliative care literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Ahmedzai and Davis, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Homsi et al, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross, 2014</a>].</p><ul><li>CKS were unable to find good quality trial data to support any of the symptomatic treatments recommended in this palliative care population.<ul><li>A Cochrane systematic review (search date: up to May 2010) compared pharmacological (for example cough suppressants, corticosteroids and nebulized local anaesthetics) and non-pharmacological interventions (for example brachytherapy, laser therapy and photodynamic therapy) for the management of cough in palliative care. They included 17 studies and no recommendations for practice could be made due to a lack of good quality evidence from the included studies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Molassiotis et al, 2015</a>].</li></ul></li><li>Simple measures enable people with cancer to exert some control over cough treatment, and are often comforting:<ul><li>There is little published evidence available on the use of nebulized drugs in the symptomatic management of people with cough (and/or breathlessness) related to malignancy and therefore CKS has based this recommendation on expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross, 2014</a>].</li><li>Simple Linctus BP has a high sugar content that simulates saliva production and soothes the oropharynx. The associated swallowing may also interfere with the cough reflex. Any beneficial effect is short lived, so increasing the dose or trying another compound cough mixture is not recommended if there is no benefit [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross, 2014</a>]. In people with diabetes, consider using a sugar-free cough suppressant.</li></ul></li><li>With Pholcodine Linctus BP and Codeine Linctus BP, it has been suggested that the licensed doses are probably lower than the doses needed to relieve cough [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Fuller and Jackson, 1990</a>].</li><li>Inhaled sodium cromoglicate four times a day improves cough in people with lung cancer within 36-48 hours [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross et al, 2009</a>].</li></ul><!-- end field 0b1c0b30-52f5-4c93-8ee2-3845d9ec34cf --><!-- end item 1360b660-d094-4ac0-88ca-19eecc687914 -->","subChapters":[]}]},{"id":"0d4b9c79-0b11-54ed-b07d-782b6cd7276b","slug":"moist-cough","fullItemName":"Moist cough","depth":3,"htmlHeader":"<!-- begin field 10710680-9da7-491f-b301-88134a0c1bea --><h3>How should I manage a moist cough in palliative care?</h3><!-- end field 10710680-9da7-491f-b301-88134a0c1bea -->","summary":null,"htmlStringContent":"<!-- begin item 810df708-de77-434f-8f31-563884f61672 --><!-- begin field d6e16c51-4302-4d19-8aa8-be65757144a0 --><ul><li>Determine with the person, and their carers and family, what management interventions are appropriate for the stage of illness and the effectiveness of their cough and consider:<ul><li>Treatment of infection with an appropriate antibiotic.</li><li>Encouraging expectoration in people with an effective cough mechanism (such as those who are able to expectorate secretions):<ul><li>Use nebulized saline solution for tenacious secretions (physiotherapy in addition to nebulized saline may be of benefit, however, availability in the community may be limited). This is unsuitable for people who are unable to expectorate because use of nebulized saline can result in the production of copious liquid sputum. If considered appropriate, nebulized 0.9% saline solution should be given as 2.5 mL to 5 mL four times a day.</li><li>Use a mucolytic (such as carbocisteine or mecysteine) to reduce the viscosity of the secretions.</li></ul></li><li>Humidifying the air or oxygen (if needed) in people with a dry mouth.</li></ul></li><li>If a person is at the terminal stage of life and unable to expectorate, consider:<ul><li>Altering body positioning — coughing is not effective when supine (lying on the back).</li><li>Drying of secretions, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-secretions/\">Palliative cancer care - secretions</a>.</li><li>Using morphine as a cough suppressant.<ul><li>Cough suppressants should be avoided except in situations such as when the cough is distressing in a dying person who is too weak to expectorate. Cough suppressants may help to ensure sleep at night and to prevent exhaustion during the day.</li><li>When using an opioid cough suppressant, consider the need to prevent opioid-induced constipation, nausea, and vomiting.</li></ul></li></ul></li></ul><!-- end field d6e16c51-4302-4d19-8aa8-be65757144a0 --><!-- end item 810df708-de77-434f-8f31-563884f61672 -->","subChapters":[{"id":"984eef6e-d82e-5846-a6aa-a3bd9335329e","slug":"basis-for-recommendation-7a8","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 646e3c3c-15f8-4aff-87cb-519ae2ebe573 --><h4>Basis for recommendation</h4><!-- end field 646e3c3c-15f8-4aff-87cb-519ae2ebe573 -->","summary":null,"htmlStringContent":"<!-- begin item 7a89446d-8857-417d-9632-c5bfc6488f42 --><!-- begin field 77feb879-e45f-4ea4-a26c-48faf903845a --><p>These recommendations are based on palliative care guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">NHS Scotland, 2015</a>] and expert opinion from the palliative care literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Ahmedzai and Davis, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Ahmedzai, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross et al, 2009</a>].</p><ul><li>CKS were unable to find good quality trial data to support any of the symptomatic treatments recommended in this palliative care population.<ul><li>A Cochrane systematic review (search date: up to May 2010) compared pharmacological (for example cough suppressants, corticosteroids and nebulized local anaesthetics) and non-pharmacological interventions (for example brachytherapy, laser therapy and photodynamic therapy) for the management of cough in palliative care. They included 17 studies and no recommendations for practice could be made due to a lack of good quality evidence from the included studies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Molassiotis et al, 2015</a>].</li></ul></li><li>In the terminal phase, oral opioid cough suppressants are best when cough is causing distress, or when other symptoms (such as pain, dyspnoea, diarrhoea) are also being treated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Homsi et al, 2001</a>]. Morphine can be used to suppress a productive cough at the end of life, and morphine solution offers more flexibility because the dose can be titrated upwards against symptoms.</li><li>There is little published evidence on the use of nebulized drugs in the symptomatic management of people with cough (and/or breathlessness) related to malignancy, therefore CKS has based this recommendation on expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross et al, 2009</a>].</li><li>Mucolytic treatments may help to reduce the viscosity of the secretions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Twycross et al, 2009</a>].</li><li>Humidifying the air or oxygen can help people with a dry mouth as they may have a reduction in tracheobronchial mucus which can cause difficulty with expectoration [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">Ahmedzai, 2004</a>].</li></ul><!-- end field 77feb879-e45f-4ea4-a26c-48faf903845a --><!-- end item 7a89446d-8857-417d-9632-c5bfc6488f42 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}